ESCMID is proud to present a series of open-access websymposia in 2021.
Each websymposia will be recorded and available for on-demand viewing on the ESCMID YouTube Channel in the days following the live stream.
The websymposia will be listed below as they are announced and made available for registration.
Emmanuelle Cambau (University of Paris, APHP GHU Nord, Paris, France)
ESCMID Professional Affairs Officer
Valentijn Schweitzer (University Medical Centre Utrecht, Netherlands)
President, Trainee Association of ESCMID (TAE)
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 16:00 - 16:05 | Introduction | Emmanuelle Cambau | University of Paris, APHP GHU Nord, Paris, France |
| 16:05 - 16:25 | How much our practices differed from one place to another? | Cansu Cimen | University Medical Centre Groningen, Netherlands |
| 16:25 - 16:45 | The role of health care workers during COVID-19 | Polona Maver Vodicar Alejandro Martin Quiros | University of Ljubljana, Slovenia Hospital Universitario La Paz, Spain |
| 16:45 - 17:05 | The role of ID and CM trainees in the COVID-19 Pandemic | Kevin Bouiller Valentijn Schweitzer | CHU Besançon, France University Medical Centre Utrecht, Netherlands |
| 17:05 - 17:25 | Mental health of PhD students and medical trainees: embracing failure and maintaining self-care | Olga Vvedenskaya | Dragonfly Mental Health, USA |
| 17:25 - 17:45 | Depression and anxiety in health care professionals. What can we do about it? | Stephan Weibelzahl | PFH Private University of Applied Sciences Göttingen, Germany |
| 17:45 - 18:00 | General discussion and conclusions | Maurizio Sanguinetti | Università Cattolica del S. Cuore, Rome, Italy |
Annelies Zinkernagel (University Hospital of Zurich, Switzerland)
Jon S. Friedland (St. George’s, University of London, UK)
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 17:00 - 17:30 | Designing a vaccine from first principles: tackling SARS-CoV-2 and new variants | Andrew Pollard | University of Oxford, UK |
| 17:30 - 18:00 | mRNA vaccines: the rapid adaption of a novel technology | Steve Pascolo | University Hospital of Zurich, Switzerland |
| 18:00 - 18:30 | How important are neutralizing antibodies in the management of COVID-19? | Florian Krammer | Icahn School of Medicine at Mount Sinai (ISMMS), New York, USA |
Evelina Tacconelli (University of Verona, Italy)
Jesús Rodríguez-Baño (Hospital Universitario Virgen Macarena, Seville, Spain)
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 16:00 - 16:30 | Update on drugs with antiviral activity | Yazdan Yazdanpanah | Bichat Claude Bernard Hospital and Paris Diderot University, France |
| 16:30 - 17:00 | Updating the available evidence and prospects for immunomodulators and immunosuppressors | L.P.G. (Lennie) Derde | UMC Utrecht, Netherlands |
| 17:00 - 17:30 | Updating the available evidence and prospects for treatment and management of ventilated patients | Massimo Antonelli | Università Cattolica del Sacro Cuore, Rome, Italy |
| 17:30 - 18:00 | Panel Discussion | All speakers |
Maurizio Sanguinetti (Università Cattolica del Sacro Cuore, Rome, Italy)
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 17:00 - 17:30 | SARS-CoV-2 vaccines. The EMA perspective | Marco Cavalieri | European Medicines Agency (EMA) |
| 17:30 - 18:00 | Nationwide SARS-CoV-2 vaccination strategy: the case of Israel | Khitam Muhsen | School of Public Health, Tel Aviv University, Israel |
Jeroen Schouten (RadboudUMC, Netherlands)
Jose Ramon Pano-Pardo (Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain).
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 16:00 - 16:30 | AMS in COVID times: how important is bacterial co-infection and secondary infection in individuals with coronavirus? | Timothy M. Rawson | Imperial College, London, UK |
| 16:30 - 17:00 | AMS in COVID times: how relevant is COVID-associated Pulmonary Aspergillosis (CAPA) and what should be the treatment algorithm? | Paul Verweij | RadboudUMC, Netherlands |
| 17:00 - 17:30 | AMS in COVID times: role for biomarkers/rapid diagnostics to reduce inappropriate antibiotic use in COVID patients | Larissa May | University of California, Davis, USA |
| 17:30 - 18:00 | Why (and how) COVID-19 experience can help us rebuild antimicrobial stewardship programs | Céline Pulcini | Nancy University Hospital, France |
Maurizio Sanguinetti (Università Cattolica del Sacro Cuore, Rome, Italy)
Jacob Moran-Gilad (Ben-Gurion University, Beer Sheeva, Israel).
| Time | Presentation Title | Presenter | Affiliation |
|---|---|---|---|
| 16:00 - 16:30 | Molecular diagnostics for COVID in the vaccine era | Gilbert Greub | University Hospital Lausanne (CHUV), Switzerland |
| 16:30 - 17:00 | COVID serology - before, during and after vaccination | Mario Plebani | University of Padova, Italy |
| 17:00 - 17:30 | Laboratory assessment of SARS-CoV2 immunity | Bali Pulendran | Stanford University, USA |
| 17:30 - 18:00 | Tracking SARS-CoV2 variants through large scale genomics | Sharon Peacock | University of Cambridge, UK |
Reduced Fees
for Events
Active
Participation
Voting
Rights
Journal
Subscriptions
Eligibility
for Programmes
Eligibility for Awards
and Grants
Reduced Fees
for Events
Active
Participation
Voting
Rights
Journal
Subscriptions
Eligibility
for Programmes
Eligibility for Awards
and Grants
ECCMID 2024
34th ECCMID
27-30 April 2024 Barcelona, Spain
Save the date: the 34th European Congress of Clinical Microbiology & Infectious Diseases will take place as a hybrid event both online and in Barcelona, Spain on 27-30 April 2024.
CMI Website
eAcademy
EUCAST
